Yumita, Sae
Ogasawara, Sadahisa
Nakagawa, Miyuki
Maruta, Susumu
Okubo, Tomomi
Itokawa, Norio
Iino, Yotaro
Obu, Masamichi
Haga, Yuki
Seki, Atsuyoshi
Kogure, Tadayoshi
Ishino, Takamasa
Ogawa, Keita
Fujiwara, Kisako
Iwanaga, Terunao
Fujita, Naoto
Sakuma, Takafumi
Kojima, Ryuta
Kanzaki, Hiroaki
Koroki, Keisuke
Inoue, Masanori
Kobayashi, Kazufumi
Kiyono, Soichiro
Nakamura, Masato
Kanogawa, Naoya
Saito, Tomoko
Kondo, Takayuki
Nakagawa, Ryo
Nakamoto, Shingo
Muroyama, Ryosuke
Chiba, Tetsuhiro
Itobayashi, Ei
Atsukawa, Masanori
Koma, Yoshihiro
Azemoto, Ryosaku
Ito, Kenji
Mizumoto, Hideaki
Kato, Jun
Kato, Naoya
Article History
Received: 27 July 2022
Accepted: 17 March 2023
First Online: 31 March 2023
Declarations
:
: All procedures performed in this study involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This study was approved by the Research Ethics Committee of the Graduate School of Medicine, Chiba University (No. 3091). The study information was notified to patients through each institution. All patients had the opportunity to opt out form the study. The ethic review board approved that the informed consent could be obtained thought this process without the written informed consent for this study under Japanese regulation of retrospective analyses.
: Not applicable.
: Sadahisa Ogasawara received honoraria from Bayer, Leverkusen, Germany; Eisai, Tokyo, Japan; Eli Lilly, Indianapolis, IN, USA; Chugai Pharma, Tokyo, Japan; AstraZeneca, Cambridge, UK; and Merck & Co., Inc., Kenilworth, NJ, USA, consulting or advisory fees from Bayer, Eisai, Merck & Co., Inc., Chugai Pharma, Eli Lilly, and AstraZeneca, and research grants from Bayer, AstraZeneca, and Eisai. Masanori Atsukawa received a research grant from Eisai. Naoya Kato received honoraria from Bayer, Eisai, Sumitomo Dainippon Pharma, Tokyo, Japan, and Merck & Co., Inc.; consulting or advisory fees from Bayer and Eisai; and research grants from Bayer and Eisai. All other authors have no conflict of interest.